Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
SBIO
94
HOLDINGS
20%
ALSO IN CANC
CANC
50
HOLDINGS
34%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
NUVALENT, INC. CLASS A | 3.1% | 3.2% | 3.1% |
 |
MERUS N.V. | 3.0% | 4.5% | 3.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.4% | 3.1% | 2.4% |
|
ARCELLX, INC. | 2.4% | 3.3% | 2.4% |
|
IDEAYA BIOSCIENCES, INC. | 1.3% | 2.2% | 1.3% |
SBIO Overweight Relative to CANC
|
RHYTHM PHARMACEUTICALS, INC. | 3.6% |
|
AVIDITY BIOSCIENCES INC | 3.5% |
|
AXSOME THERAPEUTICS, INC. | 3.2% |
 |
ALKERMES PLC | 2.7% |
|
VIKING THERAPEUTICS, INC. | 2.6% |
|
ACADIA PHARMACEUTICALS INC | 2.6% |
|
CYTOKINETICS INC | 2.5% |
|
AKERO THERAPEUTICS, INC. | 2.5% |
|
KRYSTAL BIOTECH, INC. | 2.5% |
|
VAXCYTE, INC. | 2.4% |
SBIO Underweight Relative to CANC
|
BRIDGEBIO PHARMA, INC. | -5.2% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.8% |
 |
ASTRAZENECA PLC | -4.3% |
|
SUMMIT THERAPEUTICS INC | -4.2% |
|
NOVARTIS AG | -4.2% |
 |
GENMAB A/S SPONSORED ADR | -3.8% |
|
ELI LILLY & CO | -3.6% |
|
EXELIXIS INC | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |